Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. PaxMedica Inc. (PXMD) Message Board

Siblings of Autistic Kids Have Sevenfold Higher Ri

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 90
(Total Views: 84)
Posted On: 10/11/2024 4:48:04 PM
Avatar
Posted By: NetworkNewsWire
Siblings of Autistic Kids Have Sevenfold Higher Risk of Autism

Autism spectrum disorder is a developmental and neurological disorder that affects how an individual communicates and interacts with others as well as the individual behaves and learns. Now, a new study has determined that siblings of children with autism have a higher likelihood of being diagnosed with the developmental disorder.

The research was carried out by researchers from the Baby Siblings Research Consortium and the UC Davis MIND Institute.

The researchers’ objective was to determine the likelihood that a child born after an autistic child in one family would have the disorder. Huge increases in autism diagnoses, as observed in the last decade or so, led researchers to ask whether similar trends could influence autism recurrence in families, where environmental and genetic factors could play a bigger role.

For their study, the researchers collected data from 18 research sites globally, all of which were part of the Baby Siblings Research Consortium, then analyzed it. It is important to note that every site utilized evaluation tools, which are reliable for autism identification.

The researchers also gathered data on the developmental progress of each baby using the Mullen Scales of Early Learning, which measures motor, language and cognitive skills. In addition, they collected crucial demographic data from each family, including data on education levels of parents, family structure and race.

The researchers discovered that roughly 20% of siblings born after an autistic child were diagnosed with autism themselves, a rate which is roughly seven times higher than that of children without siblings who have autism. This bolsters the belief that autism runs in families, with the researchers noting that the increased chances that a younger sibling would develop autism warrants developmental surveillance.

The researchers also found that the sex of the older child with autism also influenced rates of recurrence, observing that families with a son who had autism had a rate of recurrence of 22.5% while those with a daughter who had autism had a rate of 34.7%. This reinforces the notion that girls may need a higher number of environmental or genetic risk factors to develop the condition.

In addition, the researchers observed that the recurrence of autism was higher in families of POC children, in comparison to white children.

Further, the education level of mothers was discovered to be a predictor of recurrence, with children whose moms did not have a college education having a higher likelihood of being diagnosed with the developmental condition as compared to those whose moms who had higher educational attainments.

The study’s findings were published in “Pediatrics.”

The increasing prevalence of autism is creating urgency for effective treatments for this condition to become readily available. Hopefully, entities that are focused on developing therapeutics targeting autism, such as PaxMedica Inc. (OTC: PXMD), can yield positive results sooner rather than later.

NOTE TO INVESTORS: The latest news and updates relating to PaxMedica Inc. (NASDAQ: PXMD) are available in the company’s newsroom at https://ibn.fm/PXMD

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer




(0)
(0)




PaxMedica Inc. (PXMD) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us